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1. Introduction
The completion of human genome sequence has driven the research focusing 
from structural genomics to functional genomics. Transcriptomics and proteomics 
are two main contents in the era of functional genomics. Human genome contains 
about 20,300 genes [1]. However, RNA splicing and other factors in the transcrip-
tional process from a gene to RNA result in multiple transcripts that are derived 
from the same single-one gene. Thus, human transcriptome is estimated to contain 
at least 100,000 transcripts, much more than the number of human genes. Each 
transcript guides the ribosome to synthesize an amino acid sequence of a protein. 
The synthesized protein in the ribosome must be translocated and redistributed to 
the appropriate locations to form a special conformation and interact with surround-
ing molecules, namely, a complex, to exert its biological functions. Also, protein 
is modified by many posttranslational modifications (PTMs) and even unknown 
factors in the process of translocation and redistribution. An estimated 400–600 
PTMs in human body are the main factors to cause the complexity and diversity of 
proteins, namely, protein species [2, 3] or proteoforms [4, 5]. Thus, multiple pro-
teoforms are often derived from one same transcript, and it is estimated that human 
proteome contains at least 1,000,000 proteoforms [6]. A proteoform is the basic unit 
in a proteome, and it is defined as its amino acid sequence + PTMs + spatial confor-
mation + localization + cofactors + binding partners + a function (Figure 1), which 
is the final functional performer of a gene [6]. A protein is an umbrella term for all 
proteoforms coded by the same gene. Moreover, the different proteoforms derived 
from one same gene might have different conformation and functions. Each proteo-
form has its own copy number or abundance, which can be quantified between given 
conditions [4]. Studies on proteoforms will offer much more in-depth insights into a 
proteome, which will directly lead to the discovery of reliable biomarkers to under-
stand accurate molecular mechanisms, the discovery of effective therapeutic targets, 
and for effective prediction, diagnosis, and prognostic assessment.
It is a big challenge in the methodology to study the over millions of human 
proteoforms [1, 6]. The common bottom-up mass spectrometry (MS)-based strate-
gies cannot identify proteoforms, which in fact only identify protein-coded genes, a 
protein group. This type of method includes stable isotope-labeled two-dimensional 
liquid chromatography-tandem mass spectrometry (2DLC-MS/MS) and stable 
isotope-free 2DLC-MS/MS, which only identify peptides and PTMs (Figure 2) 
[6]. Top-down MS-based strategies have been developed to identify proteoforms 
[7–9]. This type of method can identify proteoforms, which obtains the proteoform 
message including the amino acid sequence and PTMs. However, the obtained 
message of proteoform is only partial information of the above defined proteoform. 
Also, the protein must be purified prior to MS analysis, with different types of 
protein isolation techniques such as capillary zone electrophoresis (CZE) and liquid 
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chromatography (LC) [10, 11]. Another drawback is the low ratio of signal to noise 
(S/N) in the MS analysis. All of those factors result in a relative low throughput 
in identification of human proteoforms. Currently the maximum throughput of 
top-down MS is up to 5700 proteoforms corresponding to 860 proteins (Figure 2) 
[6]. Two-dimensional gel electrophoresis (2DE)-liquid chromatography-MS 
Figure 1. 
The concept and formation model of proteoform. (Reproduced from Zhan et al. [1, 6], copyright permission 
with open access policy.)
Figure 2. 
The methods to study proteoforms. (Reproduced from Zhan et al. [1, 4, 6], copyright permission with open 
access policy.)
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(2DE-LC/MS) strategy combines the top-down technique (2DE) and bottom-up 
technique (LC/MS), which is currently superhigh-throughput method to identify 
the large-scale proteoforms [1, 6, 12, 13]. With the innovating concept and practice 
of 2DE, 2DE is a real prefractionation method, which can effectively recognize 
isoelectric point (pI) and the relative mass (Mr)—two essential parameter of a 
proteoform; each 2D gel spot contains over 50 to several hundred proteoforms, and 
most of proteoforms are low-abundance. Currently, the largest 2D gel is 30 cm x 
40 cm, which can separate 10,000 2D gel spots; thus at least 500,000 or 1,000,000 
proteoforms can be identified. LC/MS can identify protein sequences and partial 
PTMs (Figure 2) [1, 13]. 2DE-LC/MS has great potential in analysis of large-scale 
proteoforms. 2DE-LC/MS and top-down MS are complementary in the achievement 
of maximum coverage of human proteoforms in a proteome.
Proteoform is the final functional format of a protein coded by a gene, which 
has important scientific merits in the fields of life sciences and medical sciences, 
and it is the research hot spot and international scientific frontiers. In the past 
1–2 years, one has gradually paid more attention to the proteoform study. A total 
of 532 publications can be obtained through searching in the PubMed dataset with 
the keyword “proteoform or proteoforms.” For example, 24 growth hormone (GH) 
proteoforms were identified with 2DE-LC/MS in human pituitary tissues [14], and 
20 and 22 kDa GH proteoforms functioned in different signaling profiles. Six pro-
lactin (PRL) proteoforms were identified with 2DE-LC/MS and 2DE-Western blot 
in human pituitary tissues, and the proportional ratio of six PRL proteoforms were 
significantly different among different subtype nonfunctional pituitary adenoma 
relative to control pituitary tissues [15]. The six PRL proteoforms bind to different 
long or short PRL receptors to exert their functions. A total of 3090 proteoforms 
were identified with liquid chromatography-MS (LC/MS), and 417 proteoforms 
were identified with sheathless CZE-MS, in seminal plasma [10]. A total of 3028 
proteoforms corresponding to 387 proteins from E. coli cells were identified with 
coupling size exclusion chromatography (SEC) to CZE-activated ion electron trans-
fer dissociation (CZE-AI-ETD) [16]. Human sperm protamine proteoforms were 
identified with a combination of top-down and bottom-up MS [17]. The glioblas-
toma [12, 13] and pituitary adenoma [13–15] tissue proteoforms were investigated 
with 2DE-LC-MS/MS. Proteoforms were identified from several cell lines (HepG2, 
glioblastoma, LEH) with 2DE-LC/MS [18]. Also, proteoform dynamics is also 
investigated underlying the senescence associated secretory phenotype [19].
In summary, development of proteoforms or protein species significantly 
enriches the concept of proteome, which is the next-generation research direction 
in the field of proteomics. 2DE-LC/MS and top-down MS are the complementary 
method to study the large-scale proteoforms. In-depth investigating proteoforms 
in a proteome with different pathophysiological conditions will directly cause to 
deeply understand disease molecular mechanisms, discover the reliable and effec-
tive therapeutic targets, and identify effective predictive, diagnostic, and prognos-
tic biomarkers. Further, each proteoform is involved in a molecular network system 
and has multiple PTMs. It is the research hot spot how different PTMs competitively 
or synergistically affect proteoform structure and functions and their involved 
molecular network system [20–24]. Molecular network-based proteoform pattern 
biomarkers will have more important scientific merits.
Proteoforms are involved in the entire life science and medical sciences. This 
book contains only a fraction of the important frontier “proteoforms,” which serve 
as a spur to stimulate and encourage researchers who study proteoforms to come 
forward with its scientific merits to research and clinical practice. This book will 
focus on the concept of proteoform, technologies to study proteoforms, and appli-
cations of proteoforms.
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Acronyms and abbreviations
CZE capillary zone electrophoresis
GH growth hormone
LC liquid chromatography
Mr. relative mass
MS mass spectrometry
MS/MS tandem mass spectrometry
pI isoelectric point
PRL prolactin
PTM posttranslational modification
S/N ratio of signal to noise
2DE two-dimensional gel electrophoresis
2DLC two-dimensional liquid chromatography
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